<p>GenCrispr Cas9-N-NLS nuclease is the recombinant <i>Streptococcus pyogenes</i> Cas9 (wt) protein with a N-terminal nucleic localization signal (NLS) that can be used for genome editing by inducing site-specific DNA double stranded breaks. Cas9 protein forms a very stable ribonucleoprotein (RNP) complex with the guide RNA (gRNA) component of the CRISPR/Cas9 system, which can localize to the nucleus immediately once entering the cell with the guide of the NLS. Compared with the mRNA or plasmid systems, transcription and translation processes are not required. This DNA-free system avoids the risk...
<p>GenCrispr Cas9-N-NLS nuclease is the recombinant <i>Streptococcus pyogenes</i> Cas9 (wt) protein with a N-terminal nucleic localization signal (NLS) that can be used for genome editing by inducing site-specific DNA double stranded breaks. Cas9 protein forms a very stable ribonucleoprotein (RNP) complex with the guide RNA (gRNA) component of the CRISPR/Cas9 system, which can localize to the nucleus immediately once entering the cell with the guide of the NLS. Compared with the mRNA or plasmid systems, transcription and translation processes are not required. This DNA-free system avoids the risk...
Shipping & Handling
Shipped In
DRY ICE
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
Regulatory & Compliance
Specifications
CLASS
Proteins, Enzymes
COUNTRY OF ORIGIN
China
*USAGE / SAFETY STATEMENT
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
SIZE
100μg (4mg/ml)
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
DRY ICE
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.